作者
Maryam Karimi, Fatemeh Gheybi, Parvin Zamani, Mohammad Mashreghi, Shiva Golmohammadzadeh, Shahrzad Amiri Darban, Ali Badiee, Mahmoud Reza Jaafari
发表日期
2020/4/30
期刊
International journal of pharmaceutics
卷号
580
页码范围
119211
出版商
Elsevier
简介
Liposomal formulations were made using Solvent-assisted active loading technology (SALT). Two formulations composed of HSPC:DPPG:Chol:DSPE-mPEG2000 (PG-LipCUR) and HSPC:Chol:DSPE-mPEG2000 (LipCUR) demonstrated good colloidal properties and the CUR-encapsulation of 82% and 89% for PG-LipCUR and LipCUR, respectively. The results showed that both formulations were stable during 6 months storage at 4 °C. The release study showed that the PG-LipCUR and LipCUR formulations are relatively stable at pH 7.4. Both formulations had higher cytotoxicity on TUBO and 4T1 cell lines in compassion with normal cells. PG-LipCUR had the higher amounts of CUR cellular uptake than LipCUR. Biodistribution studies showed that both formulations could enhance the half-life of the CUR 2–3 times compared to free CUR. The tumor accumulation of PG-LipCUR was significantly higher than …
引用总数
202020212022202320242207194